Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
You are responsible for making all arrangements necessary for you to have access to our Website.
CrossRef Antiobesity therapeutics with complementary dualagonist activities at glucagon and glucagonlike peptide 1 receptors Bong Gyu Park, Gyeong Min Kim, HyeJin Lee, Jae Ha Ryu, DongHoon Kim, JaeYoung Seong, Soojeong Kim, ZeeYong Park, YoungJoon Kim, Jaemin Lee, Jae Il Kim Diabetes, Obesity and Metabolism.2022
Yao, L., Wu, J., Koc, S
The 2016 Zubair trial with 50 Pakistani women represents the only placebo-controlled study, showing 37.5% completion rate versus 18.7% placebo (p=0.054), which failed to reach statistical significance
US$ 25.29
US$ 26.34
US$ 21.36
US$ 23.76
US$ 23.02
US$ 20.66
US$ 27.07
